Structures by: Jakupec M. A.
Total: 203
(OC-6-22)-((1R,2R)-diaminocyclohexane)bis(oxalato)platinum(IV)
C10H14N2O8Pt,2(C3H7NO)
Journal of medicinal chemistry (2014) 57, 15 6751-6764
a=8.9059(5)Å b=11.2218(6)Å c=22.0760(11)Å
α=90.00° β=90.00° γ=90.00°
(OC-6-22)-ethane-1,2-diamine(3-methylmalonato)platinum(IV)
C10H16,N2O8Pt,C3H7NO,C3H6O,H2O
Journal of medicinal chemistry (2014) 57, 15 6751-6764
a=13.8623(4)Å b=8.6180(2)Å c=18.7397(5)Å
α=90.00° β=97.8410(10)° γ=90.00°
[Chlorido(hapto^6^-p-cymene)(N-{4-hydroxyphenyl}-2-pyridinecarbothioamide)osmium(II)] chloride
c22H24ClN2OOsS,Cl
Chemical Science (2013) 4, 4 1837
a=14.4797(14)Å b=11.9305(11)Å c=13.1126(13)Å
α=90.00° β=98.591(3)° γ=90.00°
[Chlorido(hapto^6^-p-cymene)(N-{4-fluorophenyl}-2-pyridinecarbothioamide)ruthenium(II)] chloride
C22H23ClFN2RuS,C3H6O,Cl
Chemical Science (2013) 4, 4 1837
a=14.0346(9)Å b=8.6278(5)Å c=22.7026(13)Å
α=90.00° β=90.353(3)° γ=90.00°
Dichlorido(1,3,5-Triaza-7-phosphatricyclo[3.3.1.13.7]decane)(h6-benzylammonium)ruthenium(II)
C13H22Cl2N4PRu,CH4O,Cl
Chem. Sci. (2015) 6, 4 2449
a=6.9163(14)Å b=23.660(4)Å c=11.8396(19)Å
α=90.00° β=97.078(9)° γ=90.00°
Dichlorido(1,3,5-Triaza-7-phosphatricyclo[3.3.1.13.7]decane)(h6-N-benzylacetamide)ruthenium(II)
C15H23Cl2N4OPRu
Chem. Sci. (2015) 6, 4 2449
a=10.5379(5)Å b=12.8283(6)Å c=13.7451(7)Å
α=100.766(2)° β=97.279(2)° γ=91.491(2)°
N-(2-Methyl-5,11-dihydroindolo[3,2-c]quinolin-6-ylidene)-N'-(1-pyridin-2- yl-ethylidene)azine methanol solvate
C23H19N5,CH4O
Inorganica Chimica Acta (2012) 393, 252-260
a=11.4565(7)Å b=13.1693(7)Å c=13.3620(8)Å
α=90.00° β=95.346(3)° γ=90.00°
N-(2-Chloro-5,11-dihydroindolo[3,2-c]quinolin-6-ylidene)-N'-(1-pyridin-2-yl -ethylidene)azine diethanol solvate
C22H16ClN5,2(C2H6O)
Inorganica Chimica Acta (2012) 393, 252-260
a=7.4390(6)Å b=15.6393(14)Å c=21.2178(18)Å
α=90.00° β=99.794(5)° γ=90.00°
{(hapto^6^-p-Cymene)[N-(8-bromo-5,11-dihydroindolo[3,2-c]quinolin-6- ylidene)-kappaN'-(1-kappaN-pyridin-2-yl-ethylidene)]azine chloridoruthenium(II)}chloride monomethanol solvate
C32H30BrClN5Ru,CH4O,Cl
Inorganica Chimica Acta (2012) 393, 252-260
a=9.3254(5)Å b=13.5216(8)Å c=13.5306(8)Å
α=67.646(4)° β=89.989(4)° γ=85.886(3)°
N-(8-Methyl-5,11-dihydroindolo[3,2-c]quinolin-6-ylidene)-N'- (1-pyridin-2-yl-ethylidene)azine
C23H19N5
Inorganica Chimica Acta (2012) 393, 252-260
a=17.0279(16)Å b=11.1855(11)Å c=12.0305(11)Å
α=90.00° β=129.439(4)° γ=90.00°
{(hapto^6^-p-Cymene)[N-(8-methyl-5,11-dihydroindolo[3,2-c]quinolin-6- ylidene)-kappaN'-(1-kappaN-pyridin-2-yl-ethylidene)]azine chloridoosmium(II)}chloride hydrate diethyl ether solvate
C33H33ClN5Os,Cl,1.38(H2O),0.25(C4H10O)
Inorganica Chimica Acta (2012) 393, 252-260
a=11.2980(9)Å b=14.4940(12)Å c=21.3506(18)Å
α=99.901(5)° β=92.072(4)° γ=98.838(5)°
{(hapto^6^-p-Cymene)[N-(8-bromo-5,11-dihydroindolo[3,2-c]quinolin-6- ylidene)-kappaN'-(1-kappaN-pyridin-2-yl-ethylidene)]azine chloridoosmium(II)}chloride hydrate
C32H30BrClN5Os,Cl,0.75(H2O)
Inorganica Chimica Acta (2012) 393, 252-260
a=12.3508(4)Å b=13.3564(5)Å c=20.5840(8)Å
α=98.018(2)° β=95.312(2)° γ=112.859(3)°
(OC-6-33)-Dichlorido(ethane-1,2-diamine)bis{(4-methoxy)-4- oxobutanoato}platinum(IV)
C12H22Cl2N2O8Pt
Journal of medicinal chemistry (2013) 56, 1 330-344
a=8.2185(3)Å b=10.0375(4)Å c=12.4165(5)Å
α=67.002(3)° β=71.136(2)° γ=84.577(3)°
(OC-6-54)-Dichlorido(N,N-dimethyl-ethane-1,2-diamine)aquamethoxidoplatinum(IV) trifluoroacetate
C5H17Cl2N2O2Pt,C2F3O2
Journal of medicinal chemistry (2012) 55, 24 11052-11061
a=6.1836(2)Å b=8.0658(3)Å c=15.5374(7)Å
α=102.217(3)° β=92.750(3)° γ=108.655(2)°
3-Aminopyridine-2-carbaldehyde thiosemicarbazone
C7H9N5S
Journal of medicinal chemistry (2009) 52, 16 5032-5043
a=18.5732(8)Å b=5.5273(2)Å c=17.2799(7)Å
α=90.00° β=90.00° γ=90.00°
Pyridine-2-carbaldehyde N,N-dimethylthiosemicarbazone
C9H12N4S
Journal of medicinal chemistry (2009) 52, 16 5032-5043
a=7.3747(2)Å b=7.4532(2)Å c=9.6324(3)Å
α=97.192(2)° β=109.630(2)° γ=95.020(2)°
C14H16GaN10S2,C2H6O,NO3
C14H16GaN10S2,C2H6O,NO3
Journal of medicinal chemistry (2009) 52, 16 5032-5043
a=9.3441(7)Å b=9.7491(10)Å c=12.9501(13)Å
α=102.437(6)° β=95.239(5)° γ=96.569(5)°
[Bis(3-aminopyridine-2-carbaldehyde thiosemicarbazonato)- N,N,S-iron(III)] nitrate hydrate
2(C14H16FeN10S2),NO6,NO3,4(H2O)
Journal of medicinal chemistry (2009) 52, 16 5032-5043
a=9.2033(4)Å b=23.0998(11)Å c=21.2104(8)Å
α=90.00° β=92.473(3)° γ=90.00°
Trans-[Dichlorotetraindazoleruthenium(III)]chloride methanol disolvate
C30H32Cl3N8O2Ru
Journal of medicinal chemistry (2005) 48, 8 2831-2837
a=17.681(4)Å b=11.082(2)Å c=16.738(3)Å
α=90.00° β=102.46(3)° γ=90.00°
Trans-[Dichlorotetraindazoleruthenium(II)]acetone disolvate
C34H36Cl2N8O2Ru
Journal of medicinal chemistry (2005) 48, 8 2831-2837
a=10.891(2)Å b=13.279(3)Å c=14.399(3)Å
α=65.66(3)° β=69.04(3)° γ=68.36(3)°
(OC-6-33)-Diamminebis(3-carboxypropanoato)dichloroplatinum(IV) diethyl ether solvate
C12H26Cl2N2O9Pt
Journal of medicinal chemistry (2007) 50, 26 6692-6699
a=23.5231(10)Å b=10.6395(4)Å c=8.1822(3)Å
α=90.00° β=90.00° γ=90.00°
9-Nitro-6-(alpha-picolylamino)-7,12-dihydroindolo[3,2-d][1]benzazepine
C22H17N5O2
Journal of medicinal chemistry (2007) 50, 25 6343-6355
a=10.8951(10)Å b=20.050(2)Å c=8.6412(9)Å
α=90.00° β=90.160(4)° γ=90.00°
(hapto^6^-p-Cymene)[9-pyridin-kappaN-2-yl-(E)-methylidene)amino-kappaN-7,12- dihydroindolo[3,2-d][1]benzazepin-6(5H)-one]chloroosmium(II) chloride acetone solvate
C35H36Cl2N4O2Os
Journal of medicinal chemistry (2007) 50, 25 6343-6355
a=9.876(2)Å b=9.6263(19)Å c=17.460(4)Å
α=90.00° β=104.32(3)° γ=90.00°
(hapto^6^-p-Cymene){9-nitro-6-[(alpha-picolyl-kappaN)imino-kappaN]-7,12- dihydroindolo[3,2-d][1]benzazepine}chlororuthenium(II) chloride diethanol solvate
C36H43Cl2N5O4Ru
Journal of medicinal chemistry (2007) 50, 25 6343-6355
a=12.2485(4)Å b=12.6418(5)Å c=14.3132(5)Å
α=95.421(2)° β=108.122(2)° γ=118.054(2)°
(hapto^6^-p-Cymene){9-nitro-6-[(alpha-picolyl-kappaN)imino-kappaN]-7,12- dihydroindolo[3,2-d][1]benzazepine}chlororuthenium(II) chloride diethanol water solvate
C36H45Cl2N5O5Ru
Journal of medicinal chemistry (2007) 50, 25 6343-6355
a=10.771(2)Å b=25.040(5)Å c=13.238(3)Å
α=90.00° β=91.84(3)° γ=90.00°
(hapto^6^-p-Cymene){9-bromo-6-[(alpha-picolyl-kappaN)imino-kappaN]-7,12- dihydroindolo[3,2-d][1]benzazepine}chloroosmium(II) chloride ethanol water solvate
C130H133Br4Cl8N16O3.5Os4
Journal of medicinal chemistry (2007) 50, 25 6343-6355
a=13.8319(5)Å b=14.1376(5)Å c=18.3912(6)Å
α=98.511(2)° β=107.338(2)° γ=102.012(2)°
(hapto^6^-p-Cymene){9-nitro-6-[(alpha-picolyl-kappaN)imino-kappaN]-7,12- dihydroindolo[3,2-d][1]benzazepine}chloroosmium(II) chloride ethanol water solvate
C35.9H42.95Cl2N5O4.08Os
Journal of medicinal chemistry (2007) 50, 25 6343-6355
a=12.2836(4)Å b=12.6756(4)Å c=14.2592(6)Å
α=95.491(2)° β=107.998(2)° γ=118.072(2)°
(hapto^6^-p-Cymene){6-[(alpha-picolyl-kappaN)imino-kappaN]-7,12- dihydroindolo[3,2-d][1]benzazepine}chloroosmium(II) chloride water solvate
C32H32.5Cl2N4O0.25Os
Journal of medicinal chemistry (2007) 50, 25 6343-6355
a=13.9580(7)Å b=14.0949(7)Å c=18.3531(9)Å
α=96.749(3)° β=108.022(3)° γ=102.050(3)°
Bis[((1-benzyl-2-methyl-3-(oxo-κO)-pyridine-4(1H)- thionato-κS)(η6-p-cymene) ruthenium(II)) iodide]
2(I),C46H52N2O2Ru2S2,CH4O
Dalton transactions (Cambridge, England : 2003) (2020) 49, 44 15693-15711
a=19.6766(16)Å b=10.0026(10)Å c=24.018(2)Å
α=90° β=92.308(4)° γ=90°
[(Thioatocarbonyldiamine-κS)(1-benzyl-2-methyl-3-oxo-κO-pyridine-4(1H)- thionato-κS)](η6-p-cymene)ruthenium(II)] chloride
C24H30N3ORuS2,Cl
Dalton transactions (Cambridge, England : 2003) (2020) 49, 44 15693-15711
a=10.107(2)Å b=11.107(2)Å c=12.096(2)Å
α=90° β=108.775(8)° γ=90°
[(1-Methyl-1H-imidazole-κN3)(1,2-dimethyl-3-oxo-κO-pyridine-4(1H)- thionato-κS)(η6-p-cymene)ruthenium(II)] hexafluorophosphate
C21H28N3ORuS,F6P
Dalton transactions (Cambridge, England : 2003) (2020) 49, 44 15693-15711
a=9.5074(2)Å b=10.0971(3)Å c=13.5952(4)Å
α=74.3060(9)° β=77.5332(9)° γ=87.8246(11)°
[(1,3,5-Triaza-7-phosphaadamantane-κP)(1,2-Dimethyl-3-oxo-κO-pyridine- 4(1H)-thionato-κS)(η6-p-cymene)ruhtenium(II)] hexafluorophosphate
C23H34N4OPRuS,F6P
Dalton transactions (Cambridge, England : 2003) (2020) 49, 44 15693-15711
a=8.8476(5)Å b=11.4425(6)Å c=13.8462(7)Å
α=82.475(2)° β=79.907(2)° γ=88.353(2)°
[(1-Methyl-1H-imidazole-κN3)(1-benzyl-2-methyl-3-oxo-κO-pyridine-4(1H)- thionato-κS)(η5-1,2,3,4,5-pentamethylcyclopentadienyl)rhodium(III)] hexafluorophosphate
C27H33N3ORhS,F6P
Dalton transactions (Cambridge, England : 2003) (2020) 49, 44 15693-15711
a=9.8382(3)Å b=12.2093(4)Å c=14.1367(5)Å
α=67.1738(11)° β=80.8485(12)° γ=68.3017(11)°
[(1-Methyl-1H-imidazole-κN3)(1-benzyl-2-methyl-3-oxo-κO-pyridine-4(1H)- thionato-κS)(η6-p-cymene)ruhtenium(II)] hexafluorophosphate
C27H32N3ORuS,F6P
Dalton transactions (Cambridge, England : 2003) (2020) 49, 44 15693-15711
a=10.3415(3)Å b=11.8930(3)Å c=13.3257(4)Å
α=67.1050(10)° β=88.0280(10)° γ=76.6230(10)°
[(1-Methyl-1H-imidazole-κN3)(1-benzyl-2-methyl-3-oxo-κO-pyridine-4(1H)- thionato-κS)(η5-1,2,3,4,5-pentamethylcyclopentadienyl)iridium(III)] hexafluorophosphate
C27H33IrN3OS,F6P
Dalton transactions (Cambridge, England : 2003) (2020) 49, 44 15693-15711
a=9.8020(5)Å b=12.3228(6)Å c=13.9774(7)Å
α=68.0585(16)° β=81.3239(17)° γ=69.4402(17)°
[(1,3,5-Triaza-7-phosphaadamantane-κP)(1-benzyl-2-methyl-3-oxo-κO-pyridine- 4(1H)-thionato-κS)(η5-1,2,3,4,5-pentamethylcyclopentadienyl)rhodium(III)] hexafluorophosphate
C29H39N4OPRhS,F6P
Dalton transactions (Cambridge, England : 2003) (2020) 49, 44 15693-15711
a=9.4865(4)Å b=13.5259(8)Å c=13.5730(8)Å
α=68.784(2)° β=84.539(3)° γ=78.200(3)°
[(1-Methyl-1H-imidazole-κN3)(1,2-dimethyl-3-oxo-κO-pyridine-4(1H)-thionato-κS)(η5-1,2,3,4,5-pentamethylcyclopentadienyl)rhodium(III)] hexafluorophosphate
C21H29N3ORhS,F6P
Dalton transactions (Cambridge, England : 2003) (2020) 49, 44 15693-15711
a=8.7282(5)Å b=16.3364(10)Å c=17.8947(11)Å
α=93.913(2)° β=97.756(2)° γ=90.927(3)°
[(1,3,5-Triaza-7-phosphaadamantane-κP)(1,2-Dimethyl-3-oxo-κO-pyridine-4(1H)-thionato-κS)(η5-1,2,3,4,5-pentamethylcyclopentadienyl)rhodium(III)]hexafluorophosphate
0.5(C23H35N4OPRhS),0.5(C23H34N4OPRhS),F6P
Dalton transactions (Cambridge, England : 2003) (2020) 49, 44 15693-15711
a=21.070(3)Å b=9.9943(14)Å c=31.846(4)Å
α=90° β=99.318(5)° γ=90°
[(1,3,5-Triaza-7-phosphaadamantane-κP)(1-benzyl-2-methyl-3-oxo-κO-pyridine- 4(1H)-thionato-κS)(η6-p-cymene)ruthenium(II)] hexafluorophosphate
C29H38N4OPRuS,2(CH2Cl2),F6P
Dalton transactions (Cambridge, England : 2003) (2020) 49, 44 15693-15711
a=12.3099(3)Å b=12.4123(4)Å c=14.4636(4)Å
α=65.2024(11)° β=70.4638(11)° γ=77.0040(11)°
[(1-Methyl-1H-imidazole-κN3)(1,2-dimethyl-3-oxo-κO-pyridine-4(1H)- thionato-κS)(η5-1,2,3,4,5-pentamethylcyclopentadienyl)iridium(III)] hexafluorophosphate
C21H29IrN3OS,F6P
Dalton transactions (Cambridge, England : 2003) (2020) 49, 44 15693-15711
a=8.77040(10)Å b=16.4092(2)Å c=18.0771(3)Å
α=93.7892(5)° β=97.5756(5)° γ=90.7492(5)°
[(3-Methyl-4-oxo-(1H-κN2-pyrazol-1-yl)-1,4-dihydronaphtalene-1,2-bis(olato)-κO1-κO2)(η6-p-cymene)ruthenium(II)]
C24H24N2O3Ru,C3H6O,H2O
Dalton transactions (Cambridge, England : 2003) (2020) 49, 5 1393-1397
a=32.8559(11)Å b=8.4989(4)Å c=18.2283(7)Å
α=90° β=96.9960(17)° γ=90°
[(3-Methyl-1-(4-methyl-1H-κN2-pyrazol-1-yl)-4-oxo-1,4-dihydronaphtalene-1,2-bis(olato)-κO1-κO2)(η6-p-cymene)osmium(II)]
C25H26N2O3Os
Dalton transactions (Cambridge, England : 2003) (2020) 49, 5 1393-1397
a=16.3690(9)Å b=7.6784(4)Å c=18.1186(10)Å
α=90° β=110.5999(13)° γ=90°
3-methyl-1-(4-methyl-1H-κN2-pyrazol-1-yl)-4-oxo-1,4-dihydronaphthalene-1,2-bis(olato)-κO1-κO2)(η6-p-cymene)ruthenium(II)
C25H26N2O3Ru
Dalton transactions (Cambridge, England : 2003) (2020) 49, 5 1393-1397
a=9.6758(2)Å b=14.2466(3)Å c=17.8729(4)Å
α=71.6959(13)° β=84.0849(14)° γ=72.7405(13)°
[(1-(1H-κN2-indazol-1-yl)-3-methyl-4-oxo-1,4-dihydronaphtalene-1,2-bis(olato)-κO1-κO2))(η6-p-cymene)ruthenium(II)]
C28H26N2O3Ru,0.09(C8H20O2)
Dalton transactions (Cambridge, England : 2003) (2020) 49, 5 1393-1397
a=11.4410(2)Å b=15.6073(3)Å c=17.4184(3)Å
α=107.7827(7)° β=99.4000(7)° γ=108.5729(6)°
[(1-(6-amino-1H-κN2-indazol-1-yl)-3-methyl-4-oxo-1,4-dihydronaphtalene-1,2-bis(olato)-κO1-κO2))(η6-p-cymene)ruthenium(II)]
C28H27N3O3Ru
Dalton transactions (Cambridge, England : 2003) (2020) 49, 5 1393-1397
a=10.9871(9)Å b=9.5021(7)Å c=27.626(2)Å
α=90° β=98.361(3)° γ=90°
[(3-Methyl-4-oxo-(1H-κN2-pyrazol-1-yl)-1,4-dihydronaphtalene -1,2-bis(olato)-κO1-κO2)(η6-p-cymene)osmium(II)]
C24H24N2O3Os,H2O
Dalton transactions (Cambridge, England : 2003) (2020) 49, 5 1393-1397
a=11.8354(6)Å b=14.6547(7)Å c=12.6306(6)Å
α=90° β=110.4966(15)° γ=90°
[(1-(1H-κN2-indazol-1-yl)-3-methyl-4-oxo-1,4-dihydronaphtalene-1,2-bis(olato)-κO1-κO2))(η6-p-cymene)osmium(II)]
C28H26N2O3Os
Dalton transactions (Cambridge, England : 2003) (2020) 49, 5 1393-1397
a=11.4724(3)Å b=15.5715(4)Å c=17.4570(5)Å
α=107.6878(10)° β=99.3524(10)° γ=108.3467(10)°
[(1-(4-amino-1H-κN2-pyrazol-1-yl)-3-methyl-4-oxo-1,4-dihydronaphtalene-1,2-bis(olato)-κO1-κO2))(η6-p-cymene)ruthenium(II)]
C24H25N3O3Ru
Dalton transactions (Cambridge, England : 2003) (2020) 49, 5 1393-1397
a=11.3136(9)Å b=23.5155(17)Å c=17.8647(15)Å
α=90° β=102.414(3)° γ=90°
C5H14Cl2N2O2PtS
C5H14Cl2N2O2PtS
New Journal of Chemistry (2017) 41, 14 6840
a=7.7950(7)Å b=8.6094(9)Å c=9.4837(9)Å
α=99.166(8)° β=91.628(8)° γ=114.355(9)°
C10H13Cl2F3N2O2PtS
C10H13Cl2F3N2O2PtS
New Journal of Chemistry (2017) 41, 14 6840
a=7.1487(4)Å b=8.9180(5)Å c=13.5059(9)Å
α=82.385(5)° β=87.679(5)° γ=66.909(6)°
C9H22N2O3PtS2
C9H22N2O3PtS2
New Journal of Chemistry (2017) 41, 14 6840
a=9.3250(8)Å b=18.8767(15)Å c=17.497(2)Å
α=90° β=90° γ=90°
C4H12Cl2N2O2PtS
C4H12Cl2N2O2PtS
New Journal of Chemistry (2017) 41, 14 6840
a=8.0458(6)Å b=11.8336(7)Å c=12.2420(15)Å
α=90° β=112.759(8)° γ=90°
C9H14Cl2N2O2PtS,CH4O
C9H14Cl2N2O2PtS,CH4O
New Journal of Chemistry (2017) 41, 14 6840
a=7.7751(2)Å b=15.9278(5)Å c=13.8379(4)Å
α=90° β=103.110(3)° γ=90°
C2H6Cl3OPtS,C5H13N2O
C2H6Cl3OPtS,C5H13N2O
New Journal of Chemistry (2017) 41, 14 6840
a=6.5859(2)Å b=19.2634(7)Å c=12.7960(5)Å
α=90° β=116.115(3)° γ=90°
Bis(diammine)(hapto$6!-p-cymene)chlorido-ruthenium(ii) hexafluorophosphate
C10H20ClN2Ru,F6P
Dalton Transactions (2009) 17 3334-3339
a=8.0544(2)Å b=8.8166(2)Å c=11.2876(3)Å
α=87.861(2)° β=88.256(2)° γ=78.272(2)°
Tris(mu!2$-methoxido)-bis(hapto$6!-p-cymene)-di-osmium(ii) hexafluorophosphate
C23H37O3Os2,F6P
Dalton Transactions (2009) 17 3334-3339
a=11.2483(3)Å b=13.6694(4)Å c=34.2630(9)Å
α=90.00° β=90.00° γ=90.00°
C9H13Cl2N3O4PtS
C9H13Cl2N3O4PtS
New Journal of Chemistry (2017) 41, 14 6840
a=7.0238(3)Å b=9.0811(4)Å c=12.9083(3)Å
α=91.147(3)° β=94.584(3)° γ=111.834(4)°
C11H17N3O5PtS2
C11H17N3O5PtS2
New Journal of Chemistry (2017) 41, 14 6840
a=8.7261(2)Å b=10.2167(3)Å c=18.8842(4)Å
α=74.480(2)° β=80.247(2)° γ=87.869(2)°
[((2-κN)-1H-Indazole)(1-benzyl-4-(2-κC)-phenyl-1,2,3-(3-κN)-triazolato)(η6-p-cymene)ruthenium(II)] nitrate
2(C32H32N5Ru),H2O,2(NO3)
Dalton transactions (Cambridge, England : 2003) (2018) 47, 13 4625-4638
a=10.6875(11)Å b=22.259(2)Å c=25.861(3)Å
α=90° β=90.648(4)° γ=90°
[(S-(Methylsulfanyl)methane)(1-benzyl-4-(2-\?C)-phenyl-1,2,3-(3-\?N)-triazolato)(\?6-p-cymene)ruthenium(II)] nitrate
C27H32N3RuS,NO3
Dalton transactions (Cambridge, England : 2003) (2018) 47, 13 4625-4638
a=9.8204(5)Å b=11.5773(6)Å c=15.0588(9)Å
α=98.178(2)° β=107.253(2)° γ=113.792(2)°
[(κN-1,3-Benzothiazole)(1-benzyl-4-(2-κC)-phenyl-1,2,3-(3-κN)-triazolato)(η6-p-cymene)ruthenium(II)] nitrate
C32H31N4RuS,CH2Cl2,NO3,0.5(H2O)
Dalton transactions (Cambridge, England : 2003) (2018) 47, 13 4625-4638
a=12.0373(8)Å b=13.4469(8)Å c=20.7463(15)Å
α=95.649(2)° β=95.099(3)° γ=98.748(2)°
Fac,cis-[RuII(CO)3Cl2(MBI)]
C11H8Cl2N2O3Ru
Dalton transactions (Cambridge, England : 2003) (2017) 46, 9 3025-3040
a=7.4138(9)Å b=20.935(3)Å c=9.771(1)Å
α=90.00° β=109.94(1)° γ=90.00°
Cis,trans-[RuII(CO)2Cl2(MBI)2]
C18H16Cl2N4O2Ru
Dalton transactions (Cambridge, England : 2003) (2017) 46, 9 3025-3040
a=12.818(5)Å b=11.653(5)Å c=13.918(5)Å
α=90.00° β=105.766(5)° γ=90.00°
Fac,cis-[RuII(CO)3Cl2(DMBI)]
C12H10Cl2N2O3Ru
Dalton transactions (Cambridge, England : 2003) (2017) 46, 9 3025-3040
a=10.4194(3)Å b=10.4212(4)Å c=14.7120(5)Å
α=90.00° β=90.00° γ=90.00°
(OC-6-43)-Dichlorido(N,N-dimethyl-ethane-1,2-diamine)dihydro- xidoplatinum(IV)
C4H14Cl2N2O2Pt
Dalton transactions (Cambridge, England : 2003) (2011) 40, 32 8187-8192
a=23.064(5)Å b=23.064(5)Å c=7.5597(16)Å
α=90.00° β=90.00° γ=90.00°
(OC-6-43)-Dichlorido(N,N-dimethyl-ethane-1,2- diamine)hydroxido(4-methoxy-4-oxobutanoato)platinum(IV)
C9H20Cl2N2O5Pt
Dalton transactions (Cambridge, England : 2003) (2011) 40, 32 8187-8192
a=8.1295(3)Å b=8.3664(3)Å c=11.0750(4)Å
α=89.567(3)° β=79.707(2)° γ=84.467(2)°
C19H23Cl2O6OsP,0.35(O)
C19H23Cl2O6OsP,0.35(O)
Dalton transactions (Cambridge, England : 2003) (2010) 39, 31 7345-7352
a=8.7180(4)Å b=14.8768(7)Å c=17.0012(8)Å
α=90.00° β=90.00° γ=90.00°
3-Aminopyridine-2-carbaldehyde-thiosemicarbazone-dichlorido- zinc(ii) monoethanol solvate
C7H9Cl2N5SZn,C2H6O
Dalton transactions (Cambridge, England : 2003) (2010) 39, 3 704-706
a=11.4639(7)Å b=10.2716(5)Å c=12.7509(7)Å
α=90.00° β=99.422(4)° γ=90.00°
N-(4-amino-2,2,6,6-tetramethylpiperidinyloxyl)-6-N-(2- methylaminopyridine)-7,12-dihydroindolo-(3,2-d)(1)benzazepine-9- carboxamide methanol solvate
C32H35N6O2,CH4O
Chem.Commun. (2012) 48, 8559
a=17.778(2)Å b=26.576(3)Å c=12.4884(12)Å
α=90.00° β=90.00° γ=90.00°
Chlorido[3-(oxo-kappaO)-2-(4-methylphenyl)-chromen-4(1H)- onato-kappaO](hapto^6^-p-cymene)ruthenium(II)
C26H25ClO3Ru,CH4O
Chem.Commun. (2012) 48, 4839
a=7.8882(5)Å b=11.9690(9)Å c=13.5794(11)Å
α=74.879(5)° β=73.366(4)° γ=89.101(4)°
[(Chlorido)(3-(3-methylbut-2-en-1-yl)-1,4-dioxo-kappaO1-1,4-dihydronaphthalen-2-olato-kappaO2) (p-cymene)ruthenium(II)]
C25H27ClO3Ru
Chem.Commun. (2013) 49, 3348
a=12.8956(5)Å b=11.8913(4)Å c=14.2756(5)Å
α=90.00° β=98.501(2)° γ=90.00°
[(Chlorido)(3-(3-methylbut-2-en-1-yl)-1,4-dioxo-kappaO1-1,4-dihydronaphthalen-2-olato-kappaO2) (p-cymene)osmium(II)]
C25H27ClO3Os
Chem.Commun. (2013) 49, 3348
a=13.4764(4)Å b=8.4120(2)Å c=21.0225(5)Å
α=90.00° β=107.9860(10)° γ=90.00°
N-(9-Carboxamide)-N-(4-amino-2,2,6,6-tetramethylpiperidinooxy)-7,12-dihydroindolo- [3,2-d][1]benzazepin-6(5H)-ylidene)-N'-(1-pyridin-2-yl-ethyliden]azin-5-ide- chlorido-copper(II) tetrahydrofurane solvate
2(C33H35ClCuN7O2
Chem.Commun. (2013) 49, 10007
a=12.7891(7)Å b=28.6933(15)Å c=11.9318(6)Å
α=90.00° β=104.934(3)° γ=90.00°
Dichlorido(hapto^6^-N-benzylmaleimide)(1,3,5-triaza-7-phospha- tricyclo[3.3.1.1]decane)ruthenium(II)
C17H21Cl2N4O2PRu,CH4O
Chem.Commun. (2012) 48, 1475
a=14.2423(7)Å b=11.6629(6)Å c=13.1191(6)Å
α=90.00° β=99.589(2)° γ=90.00°
Chlorido(hapto^6^-p-cymene){5-oxo-2-((diphenylposhphoramido)methyl)-4H-pyronato}ruthenium(II)]
C28H29ClNO6PRu
Dalton transactions (Cambridge, England : 2003) (2014) 43, 26 9851-9855
a=15.998(3)Å b=16.226(4)Å c=10.5737(18)Å
α=90.00° β=105.258(6)° γ=90.00°
Catena-(sodium-bis(nitromethane)-trans-[tetra-miu-chlorido-bis(1-ethylindazole)ruthenate(III)
C18H20Cl4N4Ru,2(CH3NO2),Na
Dalton transactions (Cambridge, England : 2003) (2015) 44, 2 659-668
a=7.6282(4)Å b=25.0359(15)Å c=7.5616(5)Å
α=90.00° β=110.6095(18)° γ=90.00°
Tetrabutylammonium trans-[tetrachloridobis(1-ethylindazole)ruthenate]acetone solvate
C18H20Cl4N4Ru,C16H36N,2(C3H6O)
Dalton transactions (Cambridge, England : 2003) (2015) 44, 2 659-668
a=12.3520(17)Å b=24.580(2)Å c=14.773(2)Å
α=90.00° β=102.934(2)° γ=90.00°
Tetrabutylammonium trans-[tetrachloridobis(1-methylindazole)ruthenate(III)] acetone solvate'
C16H16Cl4N4Ru,0.75(C3H6O)
Dalton transactions (Cambridge, England : 2003) (2015) 44, 2 659-668
a=12.1585(5)Å b=23.9977(9)Å c=14.8897(6)Å
α=90.00° β=104.0629(14)° γ=90.00°
3-Hydroxy-6-methyl-2-(p-tolyl)-4H-pyran-4-thione
C13H12O2S
Dalton transactions (Cambridge, England : 2003) (2015) 45, 2 724-733
a=11.1036(4)Å b=6.9087(2)Å c=14.7366(5)Å
α=90° β=101.0720(13)° γ=90°
Chlorido{3-(oxo-?O)-2(-4-fluorophenyl)-6-methyl-pyran-4(1H)-thionato-?S}(?5-1,2,3,4,5-pentamethylcyclopentadienyl)rhodium(III)
C22H23Cl0.25FO2RhS,0.75(Cl)
Dalton transactions (Cambridge, England : 2003) (2015) 45, 2 724-733
a=8.0870(5)Å b=8.4811(4)Å c=30.4205(17)Å
α=90° β=90° γ=90°
Chlorido{3-(oxo-?O)-2-(4-methoxyphenyl)-6-methyl-pyran-4(1H)-thionato-?S}(?5-1,2,3,4,5 pentamethylcyclopentadienyl) rhodium(III)
C23H26ClO3RhS,C3H7
Dalton transactions (Cambridge, England : 2003) (2015) 45, 2 724-733
a=27.7598(10)Å b=8.3099(3)Å c=22.7034(9)Å
α=90° β=105.2325(11)° γ=90°
Chlorido{3-(oxo-?O) 2-(4-methoxyphenyl)-6-methyl-pyran-4(1H)-thionato-?S}(?6-p-cymene)ruthenium(II)
C23H25ClO3RuS
Dalton transactions (Cambridge, England : 2003) (2015) 45, 2 724-733
a=12.9626(4)Å b=13.7228(5)Å c=14.0458(5)Å
α=94.2722(13)° β=107.0275(12)° γ=107.9291(12)°
C22H23ClO3Ru
C22H23ClO3Ru
Dalton transactions (Cambridge, England : 2003) (2016) 45, 33 13091-13103
a=15.5644(8)Å b=7.9491(4)Å c=15.7175(8)Å
α=90° β=100.110(2)° γ=90°
Chlorido[2-Butyl-(3-oxo-?O)-[1,4]-naphthoquinonato- ?O4] ](h6-p-cymene)ruthenium(II)
C24H27ClO3Ru
Dalton transactions (Cambridge, England : 2003) (2016) 45, 33 13091-13103
a=9.3210(15)Å b=15.229(3)Å c=17.358(3)Å
α=93.711(6)° β=92.771(5)° γ=91.845(5)°
C13H13NO3
C13H13NO3
Dalton transactions (Cambridge, England : 2003) (2016) 45, 33 13091-13103
a=11.8478(4)Å b=6.9261(2)Å c=13.7030(4)Å
α=90° β=98.488(2)° γ=90°
C22H24ClNO3Ru
C22H24ClNO3Ru
Dalton transactions (Cambridge, England : 2003) (2016) 45, 33 13091-13103
a=18.3763(6)Å b=9.2791(3)Å c=23.9785(8)Å
α=90° β=98.607(2)° γ=90°
(hapto^6^-p-Cymene)[9-pyridin-kappaN-2-yl-(E)-methylidene)amino-kappaN-7,12- dihydroindolo[3,2-d][1]benzazepin-6(5H)-one]chlororuthenium(II) chloride acetone solvate
C35H36Cl2N4O2Ru
Journal of medicinal chemistry (2007) 50, 25 6343-6355
a=9.872(2)Å b=9.6208(19)Å c=17.434(4)Å
α=90.00° β=104.05(3)° γ=90.00°
{(hapto^6^-p-cymene)[N-(2-chloro-5,11-dihydroindolo[3,2-c]quinolin-6- ylidene)kappaN'-(1-kappaN-pyridin-2-yl-methylidene)]azine chlorido- ruthenium(II)} chloride
C31H28Cl2N5Ru,Cl
Organometallics (2011) 30, 2 273-283
a=26.5354(10)Å b=26.5354(10)Å c=9.0872(4)Å
α=90.00° β=90.00° γ=90.00°
{(hapto^6^-p-cymene)[N-(2-chloro-5,11-dihydroindolo[3,2-c]quinolin-6- ylidene)kappaN'-(1-kappaN-pyridin-2-yl-ethylidene)]azine chlorido- ruthenium(II)} chloride ethanol solvate
C32H30Cl2N5Ru,C2H6O,Cl
Organometallics (2011) 30, 2 273-283
a=10.7350(4)Å b=12.0515(4)Å c=25.1678(9)Å
α=90.00° β=94.293(2)° γ=90.00°
{(hapto^6^-p-cymene)[N-(2-methyl-5,11-dihydroindolo[3,2-c]quinolin-6- ylidene)kappaN'-(1-kappaN-pyridin-2-yl-ethylidene)]azine chlorido- osmium(II)} chloride hydrate
C33H33ClN5Os,0.5(O2),Cl
Organometallics (2011) 30, 2 273-283
a=11.690(2)Å b=21.276(4)Å c=25.898(4)Å
α=90.00° β=102.712(9)° γ=90.00°
{(hapto^6^-p-cymene)[N-(2-chloro-5,11-dihydroindolo[3,2-c]quinolin-6- ylidene)kappaN'-(1-kappaN-pyridin-2-yl-methylidene)]azine chlorido- osmium(II)} chloride diethyl ether water solvate
4(C31H28Cl2N5Os),2(C2H5O2),O3,4(Cl)
Organometallics (2011) 30, 2 273-283
a=17.2834(5)Å b=14.0348(5)Å c=29.4680(11)Å
α=90.00° β=106.416(4)° γ=90.00°
{(hapto^6^-p-cymene)[N-(5,11-dihydroindolo[3,2-c]quinolin-6- ylidene)kappaN'-(1-kappaN-pyridin-2-yl-ethylidene)]azine chlorido- ruthenium(II)} chloride hydrate
C32H31ClN5Ru,0.2(O4),Cl,0.9(O)
Organometallics (2011) 30, 2 273-283
a=10.4899(3)Å b=11.8881(3)Å c=25.1390(8)Å
α=90.00° β=95.195(2)° γ=90.00°
{(hapto^6^-p-cymene)[N-(2-methyl-5,11-dihydroindolo[3,2-c]quinolin-6- ylidene)kappaN'-(1-kappaN-pyridin-2-yl-methylidene)]azine chlorido- ruthenium(II)} chloride
C34H36.4Cl2N5O0.7Ru
Organometallics (2011) 30, 2 273-283
a=10.6834(11)Å b=12.0598(12)Å c=25.482(3)Å
α=90.00° β=93.080(7)° γ=90.00°
Chlorido[2-methyl-3-(oxo-kappaO)-pyran-4-(1H)-thionato-kappaS] (hapto^6^-p-cymene)ruthenium(II)
C16H19ClO2RuS
Organometallics (2009) 28, 15 4249
a=8.3191(2)Å b=14.8407(4)Å c=12.9576(3)Å
α=90.00° β=99.7690(10)° γ=90.00°
[Chlorido(η^6^-p-cymene)(nalidixicato-κ^2^O,O)ruthenium(II)] toluene solvate
C22H25ClN2O3Ru,C7H8
Organometallics (2011) 30, 9 2506-2512
a=12.6517(3)Å b=9.5094(2)Å c=23.2404(4)Å
α=90.00° β=97.5490(10)° γ=90.00°
[Chlorido(η^2^-p-cymene)(cinoxacinato-κ^2^O,O)ruthenium(II)] hydrate
C22H23ClN2O5Ru,H2O
Organometallics (2011) 30, 9 2506-2512
a=9.1782(2)Å b=9.2246(2)Å c=16.1067(4)Å
α=73.8780(10)° β=79.5470(10)° γ=76.6590(10)°
Trans-[Dichloridotetrakis(imidazole)ruthenium(III)]chloride
C12H16Cl3N8Os
Inorganic Chemistry (2008) 47, 7338-7347
a=9.6110(3)Å b=18.9329(9)Å c=9.6818(3)Å
α=90.00° β=90.016(2)° γ=90.00°
Cis-[Dichloridotetrakis(imidazole)ruthenium(III)]chloride
C12H16Cl3N8Os
Inorganic Chemistry (2008) 47, 7338-7347
a=11.229(2)Å b=12.259(3)Å c=7.0080(14)Å
α=90.00° β=104.11(3)° γ=90.00°
Trans-[Dichloridotetrakis(benzimidazole)ruthenium(III)] chloride methanol diethyl ether solvate
C33H38Cl3N8O2Os
Inorganic Chemistry (2008) 47, 7338-7347
a=15.7469(4)Å b=13.6976(4)Å c=16.5585(5)Å
α=90.00° β=93.710(2)° γ=90.00°
Trans-[Dichloridotetrakis(indazole)ruthenium(III)]chloride methanol water solvate
C29H30Cl3N8O2Os
Inorganic Chemistry (2008) 47, 7338-7347
a=16.9910(4)Å b=11.1273(4)Å c=16.6057(4)Å
α=90.00° β=97.557(2)° γ=90.00°